Preimplantation genetic diagnosis of the fragile X syndrome by use of linked polymorphic markers

• Published in: Prenatal diagnosis 2001-06, Vol.21 (6), p.504-511
• Main Authors: Apessos, A., Abou-Sleiman, P. M., Harper, J. C., Delhanty, J. D. A.
• Format: Article
• Language: English
• Subjects: Adult; Alleles; Biological and medical sciences; Birth control; Chromosome fragility (bloom syndrome, ataxia telangiectasia, fanconi anemia, x-linked mental retardation...); DNA Primers; Female; fragile X syndrome; Fragile X Syndrome - diagnosis; Fragile X Syndrome - genetics; Genetic Markers; Gynecology. Andrology. Obstetrics; Humans; linked polymorphisms; Male; Medical genetics; Medical sciences; Mutation - genetics; Polymerase Chain Reaction - methods; Polymorphism, Genetic; Pregnancy; Preimplantation Diagnosis - methods; preimplantation genetic diagnosis; single cell PCR; Sterility. Assisted procreation
• ISSN: 0197-3851; 1097-0223
• DOI: 10.1002/pd.111

Fragile X syndrome is the most common cause of familial mental retardation. The most common mutation is expansion of a triplet (CGG)n repeat in the 5′ untranslated region of the FMR1 gene on Xq27.3. The expansion is refractory to PCR due to preferential amplification of the smaller allele in heterozygous cells and the high GC content of the repeat and surrounding sequences. Direct detection of the normal parental alleles in preimplantation embryos has been used for preimplantation genetic diagnosis (PGD) of this disorder. However, this approach is only suitable for approximately 63% of couples due to the heterozygosity of the repeat in the normal population. As an alternative we investigated the use of polymorphic markers flanking the mutation to track the normal and premutation carrying maternal chromosomes in preimplantation embryos. Using a panel of 11 polymorphisms, six (CA)n repeats and five single nucleotide polymorphisms, diagnosis was developed for 90% of referred couples. Multiplex amplification of informative markers was tested in 300 single buccal cells from interested couples with efficiency and allele drop out (ADO) rates ranging from 69% to 96% and 6% to 18%, respectively. Use of this approach is accurate and applicable to a larger number of patients at risk of transmitting fragile X to their offspring. Copyright © 2001 John Wiley & Sons, Ltd.